as 04-01-2025 4:00pm EST
Stocks
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | N/A |
Market Cap: | 138.0M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 12.6K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.89 | EPS Growth: | N/A |
52 Week Low/High: | $8.50 - $23.99 | Next Earning Date: | 05-15-2025 |
Revenue: | N/A | Revenue Growth: | 145.01% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
EXOZ Breaking Stock News: Dive into EXOZ Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
ACCESS Newswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
The information presented on this page, "EXOZ EXOZYMES INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.